ola caster - s uhenke/dsws/caster.pdf · ola caster, uppsala monitoring centre references •...
TRANSCRIPT
![Page 1: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/1.jpg)
Facilitating statistical and visual pattern detection in large databases of
electronic health records:
Introducing the vigiTrace analytics suite
Ola Caster
DSV Data Science Seminar, Kista 4th December 2014
Acknowledgement to Niklas Norén
![Page 2: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/2.jpg)
Ola Caster, Uppsala Monitoring Centre
WHO Programme for International Drug Monitoring
![Page 3: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/3.jpg)
Ola Caster, Uppsala Monitoring Centre
![Page 4: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/4.jpg)
Ola Caster, Uppsala Monitoring Centre
![Page 5: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/5.jpg)
Ola Caster, Uppsala Monitoring Centre
Longitudinal health records
![Page 6: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/6.jpg)
Ola Caster, Uppsala Monitoring Centre
![Page 7: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/7.jpg)
Ola Caster, Uppsala Monitoring Centre
![Page 8: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/8.jpg)
Ola Caster, Uppsala Monitoring Centre
million
![Page 9: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/9.jpg)
Ola Caster, Uppsala Monitoring Centre
UMC research timeline
![Page 10: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/10.jpg)
Ola Caster, Uppsala Monitoring Centre
vigiTrace
Chronographs
(visualised temporal patterns)
Pattern detection
(screening based on calibrated self-controlled cohort analysis)
+
+
![Page 11: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/11.jpg)
Chronograph example: Adverse effect
![Page 12: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/12.jpg)
Chronograph example: Beneficial effect
![Page 13: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/13.jpg)
Which chronographs to highlight?
![Page 14: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/14.jpg)
Ola Caster, Uppsala Monitoring Centre
Calibrated self-controlled cohort analysis
![Page 15: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/15.jpg)
Drug-event overview
Chronograph
Contrasts
Drug-event list (’screening’)
Event overview
Drug overview Patient list
Patient history
Patient overview
![Page 16: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/16.jpg)
6
Nifedipine Flushing
7 20 x x
Sibutramine Oedema
assessors drugs per assessor
events per drug
![Page 17: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/17.jpg)
509
127 Already known
382 25%
Results
![Page 18: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/18.jpg)
509
127 Already known
382
291 Dismissed
91
Merit further evaluation
25% 76%
Results
![Page 19: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/19.jpg)
Ola Caster, Uppsala Monitoring Centre
Take-home messages
• Databases of electronic health records hold promise as a complementary data source in pharmacovigilance
• UMC has been involved in this scientific development for a long time, contributing both broadly and deeply
• vigiTrace facilitates detection and visualisation of relevant temporal patterns, as well as in-depth expert assessment of the underlying data
![Page 20: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/20.jpg)
Uppsala Monitoring Centre Box 1051 SE-751 40 Uppsala, Sweden Visiting address: Bredgränd 7, Uppsala Tel: +46 18 65 60 60 Fax: +46 18 65 60 88
Website: www.who-umc.org
![Page 21: Ola Caster - s uhenke/DSWS/caster.pdf · Ola Caster, Uppsala Monitoring Centre References • Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects](https://reader036.vdocument.in/reader036/viewer/2022070719/5eded7dead6a402d666a326b/html5/thumbnails/21.jpg)
Ola Caster, Uppsala Monitoring Centre
References
• Norén GN, Edwards IR. Modern methods of pharmacovigilance: detecting adverse effects of drugs. Clinical Medicine, Journal of the Royal College of Physicians, 2009. 9(5):486-489.
• Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Mining and Knowledge Discovery, 2010. 20(3):361-387.
• Norén GN, Edwards IR. Opportunities and challenges of adverse drug reaction surveillance in electronic patient records. Pharmacovigilance Review, 2010. 4(1):17-20.
• Star K, Bate A, Meyboom RHB, Edwards IR. Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern? British Journal of General Practice, 2010. 60(579):e385-e394.
• Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Brobert G, Bergvall T, Ansell D, Star K, Norén GN. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in The Health Improvement Network. Drug Safety, 2014. In press.